×
Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial. Click here for more information.

Глобальна гаряча лінія для українських пацієнтів-біженців, які беруть участь у клінічному випробуванні Amgen. Натисніть тут для отримання додаткової інформації.

Глобальная горячая линия для украинских пациентов-беженцев, участвующих в клиническом исследовании Amgen. Для получения дополнительной информации нажмите здесь.

Amgen Logo Amgen Logo
  • Main Menu
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Awards and Accolades
    • How We Operate
      • Overview
      • Corporate Governance
      • Business Ethics and Compliance
      • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research and Development Strategy
    • Pipeline
    • Amgen Science Podcasts
    • Scientific Advisory Boards
    • Amgen Competitive Grants
    • Biosimilars
    • Clinical Trials
      • Overview
      • About Clinical Trails
      • Amgen Clinical Trails
      • Clinical Trial Diversity and Representation
      • Information for Healthcare Professionals
      • Clinical Trial Transparency, Data Sharing and Disclosure Practices
      • Clinical Out-of-Hours Support program
      • Investigator Sponsored Studies
    • Scientific Community Initiatives   
      • Overview
      • Educational Outreach Program
      • Postdoctoral Fellows Program
      • Scientific Conferences Program
      • Start-Up Network Program
    • Manufacturing
      • Overview
      • Innovation
      • Quality
      • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
      • Overview
      • Who We Are
      • Our Commitment
      • What We Do
      • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Environmental, Social & Governance Report 2021
    • Environment, Social and Governance Strategy
    • Healthy People
      • Overview
      • Access to Medicines
      • Health Equity
    • Healthy Society
      • Overview
      • Diversity, Inclusion and Belonging
      • Human Capital Management
      • Community Investment and Amgen Foundation
      • Supplier Diversity
    • Healthy Planet
      • Overview
      • Environmental Sustainability
      • Supplier Sustainability
    • A Healthy Amgen
      • Overview
      • Corporate Governance
      • Business Ethics and Compliance
      • Ethical Research
      • Patient Safety
      • Product Quality
      • Cybersecurity and Data Privacy
    • Reporting and Metrics
      • Overview
      • Summary of Data
      • CDP
      • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
    • Popular Tags
      • COVID-19
      • Supporting Our Staff
      • Leveraging Our Science
      • Serving Our Communities
  • Newsroom
  • Partners
  • Investors
  • Careers
  • Amgen Worldwide
    • linkedIn-icon linkedIn-icon
    • twitter-icon twitter-icon
    • youtube-icon youtube-icon
    • facebook-icon facebook-icon
    • instagram-icon instagram-icon
  • All Stories
  • Responsibility
  • People and Culture
  • Science and Innovation
  • Patients
  • Leadership
  • Popular Tags
  • COVID-19
  • Supporting Our Staff
  • Leveraging Our Science
  • Serving Our Communities
Amgen Logo Amgen Logo
  • About
    • Overview
    • Amgen History
    • Mission and Values
    • Leadership
    • Awards and Accolades
    • How We Operate
    • Corporate Governance
    • Business Ethics and Compliance
    • Policies, Practices and Disclosures
  • Science
    • Overview
    • Research and Development Strategy
    • Pipeline
    • Amgen Science Podcasts
    • Scientific Advisory Boards
    • Amgen Competitive Grants
    • Biosimilars
    • Clinical Trials
    • About Clinical Trials
    • Amgen Clinical Trials
    • Clinical Trial Diversity and Representation
    • Information for Healthcare Professionals
    • Clinical Trial Transparency, Data Sharing and Disclosure Practices
    • Clinical Out-of-Hours Support Program
    • Investigator Sponsored Studies
    • Scientific Community Initiatives
    • Educational Outreach Program
    • Postdoctoral Fellows Program
    • Scientific Conferences Program
    • Start-Up Network Program
    • Manufacturing
    • Innovation
    • Quality
    • Reliability
  • PRODUCTS
    • Overview
    • Medical Information
    • Counterfeit Drug Statement
    • Safety Data Sheets
    • Global Patient Safety
    • Who We Are
    • Our Commitment
    • What We Do
    • Adverse Event and Product Complaint Reporting
  • Responsibility
    • Overview
    • Environmental, Social & Governance Report 2021
    • Environment, Social and Governance Strategy
    • Healthy People
    • Access to Medicines
    • Health Equity
    • Healthy Society
    • Diversity, Inclusion and Belonging
    • Human Capital Management
    • Community Investment and Amgen Foundation
    • Supplier Diversity
    • Healthy Planet
    • Environmental Sustainability
    • Supplier Sustainability
    • A Healthy Amgen
    • Corporate Governance
    • Business Ethics and Compliance
    • Ethical Research
    • Patient Safety
    • Product Quality
    • Cybersecurity and Data Privacy
    • Reporting and Metrics
    • Summary of Data
    • CDP
    • Archived Reports
  • Stories
    • All Stories
    • Responsibility
    • People and Culture
    • Science and Innovation
    • Patients
    • Leadership
    • Popular Tags
    • COVID-19
    • Supporting Our Staff
    • Leveraging Our Science
    • Serving Our Communities
  • Newsroom
  • Partners
  • Investors
  • Careers
  • amgen-worldwide-web
  1. Home
    >
  2. Newsroom
    >
  3. Company Statements
    >

Company Statements

Statements and Responses

Read our submitted letters to editors and responses to Amgen news.

  • 06.01.2022

    Amgen Statement on Russia/Ukraine
  • 07.12.2021

    Amgen Supports Industry Efforts to Address Global Access to COVID-19 Vaccines
  • 11.17.2020

    Amgen Proudly Supports PhRMA’s New Principles on Clinical Trial Diversity
  • 07.20.2020

    Oklahoma Health Care Authority and Amgen Enter into Value-Based Contract for Enbrel® (etanercept)
  • 05.07.2020

    Amgen Comments On the Supreme Court of Japan Ruling On PCSK9 Patent Infringement Litigation
  • 10.18.2019

    Amgen Comments on ICER’s Proposed Changes to the 2020 Value Assessment Framework
  • 09.09.2019

    Amgen Comments on ICER’s Proposed Methods Adaptations For Assessments of Potential Cures and Other Transformative Therapies
  • 09.04.2019

    Amgen Response in Support of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias
  • 07.11.2019

    Amgen Comments on PCSK9 Patent Litigation in Germany
  • 06.17.2019

    Amgen Comments for ICER’s 2020 Value Assessment Framework
  • 06.14.2019

    Helping Patients Understand the Price of Their Medicines
  • 05.02.2019

    Amgen Reaches Settlement With Coherus in Trade Secrets Case Regarding Pegfilgrastim
  • 04.25.2019

    Amgen Reaches Settlement Agreement To Resolve Allegations Related To Patient Assistance Programs
  • 02.21.2019

    Amgen’s Comments on ICER’s Value-Based Price Of A Cure Collaborative: Methodological Considerations
  • 02.13.2019

    Amgen’s Comments on ICER’s Price Increase Draft Protocol
  • Company Statements
    • Archives
Home Home

Stay Connected With Amgen.

  • linkedIn-icon linkedIn-icon
  • twitter-icon twitter-icon
  • youtube-icon youtube-icon
  • facebook-icon  facebook-icon
  • instagram-icon instagram-icon
Contact Us Sitemap Privacy Statement Terms of Use

© 1996-2021 Amgen Inc. All Rights Reserved. d-amgen-logo